Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix-Reference-Cited by-同舟云学术

Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix

Published:2024-04-22 Issue: Volume: Page:
ISSN:2325-8292
Container-title:LGBT Health
language:en
Short-container-title:LGBT Health

Author:

McDowell Alex¹²^ORCID,Rieu-Werden Meghan L.³,Atlas Steven J.²³,Fields Colin D.⁴,Goldstein Robert H.⁵,Gundersen Gabrielle D.⁶,Haas Jennifer S.²³,Higashi Robin T.⁷⁸,Pruitt Sandi L.⁷⁸,Silver Michelle I.⁹,Tiro Jasmin A.¹⁰,Kamineni Aruna⁶

Affiliation:

1. Health Policy Research Center, Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.

2. Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

3. Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

4. Kaiser Permanente Washington, Seattle, Washington, USA.

5. Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.

6. Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.

7. Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

8. Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, USA.

9. Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.

10. Department of Public Health Sciences, University of Chicago Biological Sciences Division, Chicago, Illinois, USA

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/lgbt.2023.0067

Reference28 articles.

1. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients

2. Pap Test Use Is Lower Among Female-to-Male Patients Than Non-Transgender Women

3. Cancer in Transgender and Gender-Diverse Persons

4. Comparison of Cervical Cancer Screen Results on Female-to-Male Transgender Patients With Female Patients